CPNE1_HUMAN - dbPTM
CPNE1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CPNE1_HUMAN
UniProt AC Q99829
Protein Name Copine-1 {ECO:0000305}
Gene Name CPNE1 {ECO:0000312|HGNC:HGNC:2314}
Organism Homo sapiens (Human).
Sequence Length 537
Subcellular Localization Nucleus . Cytoplasm . Cell membrane . Translocates to the cell membrane in a calcium-dependent manner (PubMed:21087455, PubMed:25450385).
Protein Description Calcium-dependent phospholipid-binding protein that plays a role in calcium-mediated intracellular processes. [PubMed: 14674885 Involved in the TNF-alpha receptor signaling pathway in a calcium-dependent manner]
Protein Sequence MAHCVTLVQLSISCDHLIDKDIGSKSDPLCVLLQDVGGGSWAELGRTERVRNCSSPEFSKTLQLEYRFETVQKLRFGIYDIDNKTPELRDDDFLGGAECSLGQIVSSQVLTLPLMLKPGKPAGRGTITVSAQELKDNRVVTMEVEARNLDKKDFLGKSDPFLEFFRQGDGKWHLVYRSEVIKNNLNPTWKRFSVPVQHFCGGNPSTPIQVQCSDYDSDGSHDLIGTFHTSLAQLQAVPAEFECIHPEKQQKKKSYKNSGTIRVKICRVETEYSFLDYVMGGCQINFTVGVDFTGSNGDPSSPDSLHYLSPTGVNEYLMALWSVGSVVQDYDSDKLFPAFGFGAQVPPDWQVSHEFALNFNPSNPYCAGIQGIVDAYRQALPQVRLYGPTNFAPIINHVARFAAQAAHQGTASQYFMLLLLTDGAVTDVEATREAVVRASNLPMSVIIVGVGGADFEAMEQLDADGGPLHTRSGQAAARDIVQFVPYRRFQNAPREALAQTVLAEVPTQLVSYFRAQGWAPLKPLPPSAKDPAQAPQA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
20UbiquitinationSCDHLIDKDIGSKSD
CCCCCCCCCCCCCCC
44.23-
25UbiquitinationIDKDIGSKSDPLCVL
CCCCCCCCCCCEEEE
54.38-
30UbiquitinationGSKSDPLCVLLQDVG
CCCCCCEEEEEEECC
2.17-
40PhosphorylationLQDVGGGSWAELGRT
EEECCCCCHHHCCCC
26.7922617229
45PhosphorylationGGSWAELGRTERVRN
CCCHHHCCCCCCCCC
26.43-
54PhosphorylationTERVRNCSSPEFSKT
CCCCCCCCCCHHHHE
53.1022167270
55PhosphorylationERVRNCSSPEFSKTL
CCCCCCCCCHHHHEE
30.5625159151
59PhosphorylationNCSSPEFSKTLQLEY
CCCCCHHHHEEEEEE
24.0622167270
60UbiquitinationCSSPEFSKTLQLEYR
CCCCHHHHEEEEEEE
59.5821890473
60PhosphorylationCSSPEFSKTLQLEYR
CCCCHHHHEEEEEEE
59.58-
65UbiquitinationFSKTLQLEYRFETVQ
HHHEEEEEEEHHHHH
23.00-
73UbiquitinationYRFETVQKLRFGIYD
EEHHHHHHHEEEEEE
36.9821890473
78UbiquitinationVQKLRFGIYDIDNKT
HHHHEEEEEECCCCC
2.28-
84UbiquitinationGIYDIDNKTPELRDD
EEEECCCCCCCCCCC
62.8021906983
85PhosphorylationIYDIDNKTPELRDDD
EEECCCCCCCCCCCC
28.4024719451
89SumoylationDNKTPELRDDDFLGG
CCCCCCCCCCCCCCC
43.58-
89UbiquitinationDNKTPELRDDDFLGG
CCCCCCCCCCCCCCC
43.58-
90PhosphorylationNKTPELRDDDFLGGA
CCCCCCCCCCCCCCC
72.89-
117UbiquitinationLTLPLMLKPGKPAGR
EEEEEEECCCCCCCC
37.45-
120UbiquitinationPLMLKPGKPAGRGTI
EEEECCCCCCCCCEE
39.98-
126PhosphorylationGKPAGRGTITVSAQE
CCCCCCCEEEEEEHH
16.4720068231
128PhosphorylationPAGRGTITVSAQELK
CCCCCEEEEEEHHHH
14.30-
130PhosphorylationGRGTITVSAQELKDN
CCCEEEEEEHHHHCC
18.6521712546
135AcetylationTVSAQELKDNRVVTM
EEEEHHHHCCCEEEE
52.8025953088
135UbiquitinationTVSAQELKDNRVVTM
EEEEHHHHCCCEEEE
52.8021890473
135PhosphorylationTVSAQELKDNRVVTM
EEEEHHHHCCCEEEE
52.80-
140SumoylationELKDNRVVTMEVEAR
HHHCCCEEEEEEEEC
3.68-
140UbiquitinationELKDNRVVTMEVEAR
HHHCCCEEEEEEEEC
3.68-
140AcetylationELKDNRVVTMEVEAR
HHHCCCEEEEEEEEC
3.68-
142SulfoxidationKDNRVVTMEVEARNL
HCCCEEEEEEEECCC
3.5221406390
151UbiquitinationVEARNLDKKDFLGKS
EEECCCCHHHHCCCC
58.36-
152UbiquitinationEARNLDKKDFLGKSD
EECCCCHHHHCCCCC
54.07-
152SumoylationEARNLDKKDFLGKSD
EECCCCHHHHCCCCC
54.07-
156UbiquitinationLDKKDFLGKSDPFLE
CCHHHHCCCCCHHHH
27.67-
157SumoylationDKKDFLGKSDPFLEF
CHHHHCCCCCHHHHH
54.56-
157UbiquitinationDKKDFLGKSDPFLEF
CHHHHCCCCCHHHHH
54.5621890473
158PhosphorylationKKDFLGKSDPFLEFF
HHHHCCCCCHHHHHH
49.0321712546
162UbiquitinationLGKSDPFLEFFRQGD
CCCCCHHHHHHHCCC
7.35-
163PhosphorylationGKSDPFLEFFRQGDG
CCCCHHHHHHHCCCC
43.02-
171UbiquitinationFFRQGDGKWHLVYRS
HHHCCCCCEEEEEEE
35.8619608861
171AcetylationFFRQGDGKWHLVYRS
HHHCCCCCEEEEEEE
35.8619608861
176AcetylationDGKWHLVYRSEVIKN
CCCEEEEEEEHHHHC
18.1219608861
176UbiquitinationDGKWHLVYRSEVIKN
CCCEEEEEEEHHHHC
18.1219608861
182UbiquitinationVYRSEVIKNNLNPTW
EEEEHHHHCCCCCCC
44.9821890473
187UbiquitinationVIKNNLNPTWKRFSV
HHHCCCCCCCCCCCC
42.68-
188PhosphorylationIKNNLNPTWKRFSVP
HHCCCCCCCCCCCCC
42.4124961811
190UbiquitinationNNLNPTWKRFSVPVQ
CCCCCCCCCCCCCCH
46.151906983
190MethylationNNLNPTWKRFSVPVQ
CCCCCCCCCCCCCCH
46.15-
195MethylationTWKRFSVPVQHFCGG
CCCCCCCCCHHHCCC
20.89-
195UbiquitinationTWKRFSVPVQHFCGG
CCCCCCCCCHHHCCC
20.89-
253UbiquitinationPEKQQKKKSYKNSGT
HHHHHCCCCCCCCCC
67.08-
254PhosphorylationEKQQKKKSYKNSGTI
HHHHCCCCCCCCCCE
50.66-
255PhosphorylationKQQKKKSYKNSGTIR
HHHCCCCCCCCCCEE
24.0630576142
256UbiquitinationQQKKKSYKNSGTIRV
HHCCCCCCCCCCEEE
52.29-
260PhosphorylationKSYKNSGTIRVKICR
CCCCCCCCEEEEEEE
12.8725159151
261UbiquitinationSYKNSGTIRVKICRV
CCCCCCCEEEEEEEE
5.63-
265PhosphorylationSGTIRVKICRVETEY
CCCEEEEEEEEEEEE
1.33-
325O-linked_GlycosylationMALWSVGSVVQDYDS
HHHHHHCCCCCCCCC
19.5730379171
332O-linked_GlycosylationSVVQDYDSDKLFPAF
CCCCCCCCCCCEECC
30.3430379171
386PhosphorylationALPQVRLYGPTNFAP
HCCCCEECCCCCHHH
15.5328152594
389PhosphorylationQVRLYGPTNFAPIIN
CCEECCCCCHHHHHH
38.3128152594
391PhosphorylationRLYGPTNFAPIINHV
EECCCCCHHHHHHHH
10.60-
500PhosphorylationPREALAQTVLAEVPT
CHHHHHHHHHHHCCH
16.3320860994
505PhosphorylationAQTVLAEVPTQLVSY
HHHHHHHCCHHHHHH
5.31-
522UbiquitinationAQGWAPLKPLPPSAK
HCCCCCCCCCCCCCC
43.3721890473
527UbiquitinationPLKPLPPSAKDPAQA
CCCCCCCCCCCHHHC
46.11-
529UbiquitinationKPLPPSAKDPAQAPQ
CCCCCCCCCHHHCCC
69.452190698
534UbiquitinationSAKDPAQAPQA----
CCCCHHHCCCC----
10.57-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CPNE1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CPNE1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CPNE1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PPP5_MOUSEPpp5cphysical
12522145
MYCB2_MOUSEMycbp2physical
12522145
UBE2O_MOUSEUbe2ophysical
12522145
RADI_MOUSERdxphysical
12522145
ACTB_MOUSEActbphysical
12522145
TIM13_HUMANTIMM13physical
22939629
F10A1_HUMANST13physical
22939629
TTL12_HUMANTTLL12physical
22939629
PYGB_HUMANPYGBphysical
22939629
STK3_HUMANSTK3physical
21988832

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CPNE1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-171, AND MASS SPECTROMETRY.

TOP